 Global Cancer Biologics Market 2026-2030
Global Cancer Biologics Market 2026-2030 The global cancer biologics market is forecasted to grow by USD 68000.8 mn during 2025-2030, accelerating at a CAGR of 8.2% during the forecast period. The... もっと見る
SummaryGlobal Cancer Biologics Market 2026-2030The global cancer biologics market is forecasted to grow by USD 68000.8 mn during 2025-2030, accelerating at a CAGR of 8.2% during the forecast period. The report on the global cancer biologics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating prevalence of oncology indications and aging demographics, technological advancements in recombinant dna and antibody engineering, favorable regulatory frameworks and expedited approval pathways. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data. For further information on this report, please visit - Technavio's global cancer biologics market is segmented as below: By Product • Monoclonal antibodies • Cell and gene therapy • Vaccines • Others By Route Of Administration • Injectable • Oral By Type • Breast cancer • Lung cancer • Prostate cancer • Colorectal cancer • Others By End-User • Hospitals • Specialized cancer centers • Academic and research institutes Geography • North America • US • Canada • Mexico • Europe • Germany • UK • France • Italy • Spain • The Netherlands • Asia • Rest of World (ROW) • Rest of World (ROW) This study identifies the proliferation of personalized medicine and precision oncology as one of the prime reasons driving the global cancer biologics market growth during the next few years. Also, expansion of biosimilar adoption and market penetration and integration of ai and ml in drug discovery will lead to sizable demand in the market. The report on the global cancer biologics market covers the following areas: • Global cancer biologics market sizing • Global cancer biologics market forecast • Global cancer biologics market industry analysis The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global cancer biologics market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, Biocon Ltd., Bristol Myers Squibb Co., Celltrion Co. Ltd., Cipla Inc., CSL Ltd., Dr. Reddys Laboratories Ltd., Eisai Co. Ltd., Eli Lilly and Co., Genentech Inc., Jazz Pharmaceuticals Plc, Johnson and Johnson, Kite Pharma Inc., Lupin Ltd., Merck and Co. Inc., Novartis AG, Organon and Co., Pfizer Inc., Sanofi SA. Also, the global cancer biologics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities. The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth. Table of Contents1 Executive Summary1.1 Market overview • Executive Summary - Chart on Market Overview • Executive Summary - Data Table on Market Overview • Executive Summary - Chart on Global Market Characteristics • Executive Summary - Chart on Market by Geography • Executive Summary - Chart on Market Segmentation by Product • Executive Summary - Chart on Market Segmentation by Route of Administration • Executive Summary - Chart on Market Segmentation by Type • Executive Summary - Chart on Market Segmentation by End-user • Executive Summary - Chart on Incremental Growth • Executive Summary - Data Table on Incremental Growth • Executive Summary - Chart on Company Market Positioning 2 Technavio Analysis 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria 2.2 Criticality of inputs and Factors of differentiation • Chart on Overview on criticality of inputs and factors of differentiation 2.3 Factors of disruption • Chart on Overview on factors of disruption 2.4 Impact of drivers and challenges • Chart on Impact of drivers and challenges in 2025 and 2030 3 Market Landscape 3.1 Market ecosystem • Chart on Parent Market • Data Table on - Parent Market 3.2 Market characteristics • Chart on Market characteristics analysis 3.3 Value chain analysis • Chart on Value chain analysis 4 Market Sizing 4.1 Market definition • Data Table on Offerings of companies included in the market definition 4.2 Market segment analysis • Market segments 4.3 Market size 2025 4.4 Market outlook: Forecast for 2025-2030 • Chart on Global - Market size and forecast 2025-2030 ($ million) • Data Table on Global - Market size and forecast 2025-2030 ($ million) • Chart on Global Market: Year-over-year growth 2025-2030 (%) • Data Table on Global Market: Year-over-year growth 2025-2030 (%) 5 Historic Market Size 5.1 Global Cancer Biologics Market 2020 - 2024 • Historic Market Size - Data Table on Global Cancer Biologics Market 2020 - 2024 ($ million) 5.2 Product segment analysis 2020 - 2024 • Historic Market Size - Product Segment 2020 - 2024 ($ million) 5.3 Route of Administration segment analysis 2020 - 2024 • Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million) 5.4 Type segment analysis 2020 - 2024 • Historic Market Size - Type Segment 2020 - 2024 ($ million) 5.5 End-user segment analysis 2020 - 2024 • Historic Market Size - End-user Segment 2020 - 2024 ($ million) 5.6 Geography segment analysis 2020 - 2024 • Historic Market Size - Geography Segment 2020 - 2024 ($ million) 5.7 Country segment analysis 2020 - 2024 • Historic Market Size - Country Segment 2020 - 2024 ($ million) 6 Qualitative Analysis 6.1 Impact of AI on global cancer biologics market 6.2 Impact of geopolitical conflicts on global cancer biologics market 7 Five Forces Analysis 7.1 Five forces summary • Five forces analysis - Comparison between 2025 and 2030 7.2 Bargaining power of buyers • Bargaining power of buyers - Impact of key factors 2025 and 2030 7.3 Bargaining power of suppliers • Bargaining power of suppliers - Impact of key factors in 2025 and 2030 7.4 Threat of new entrants • Threat of new entrants - Impact of key factors in 2025 and 2030 7.5 Threat of substitutes • Threat of substitutes - Impact of key factors in 2025 and 2030 7.6 Threat of rivalry • Threat of rivalry - Impact of key factors in 2025 and 2030 7.7 Market condition • Chart on Market condition - Five forces 2025 and 2030 8 Market Segmentation by Product 8.1 Market segments • Chart on Product - Market share 2025-2030 (%) • Data Table on Product - Market share 2025-2030 (%) 8.2 Comparison by Product • Chart on Comparison by Product • Data Table on Comparison by Product 8.3 Monoclonal antibodies - Market size and forecast 2025-2030 • Chart on Monoclonal antibodies - Market size and forecast 2025-2030 ($ million) • Data Table on Monoclonal antibodies - Market size and forecast 2025-2030 ($ million) • Chart on Monoclonal antibodies - Year-over-year growth 2025-2030 (%) • Data Table on Monoclonal antibodies - Year-over-year growth 2025-2030 (%) 8.4 Cell and gene therapy - Market size and forecast 2025-2030 • Chart on Cell and gene therapy - Market size and forecast 2025-2030 ($ million) • Data Table on Cell and gene therapy - Market size and forecast 2025-2030 ($ million) • Chart on Cell and gene therapy - Year-over-year growth 2025-2030 (%) • Data Table on Cell and gene therapy - Year-over-year growth 2025-2030 (%) 8.5 Vaccines - Market size and forecast 2025-2030 • Chart on Vaccines - Market size and forecast 2025-2030 ($ million) • Data Table on Vaccines - Market size and forecast 2025-2030 ($ million) • Chart on Vaccines - Year-over-year growth 2025-2030 (%) • Data Table on Vaccines - Year-over-year growth 2025-2030 (%) 8.6 Others - Market size and forecast 2025-2030 • Chart on Others - Market size and forecast 2025-2030 ($ million) • Data Table on Others - Market size and forecast 2025-2030 ($ million) • Chart on Others - Year-over-year growth 2025-2030 (%) • Data Table on Others - Year-over-year growth 2025-2030 (%) 8.7 Market opportunity by Product • Market opportunity by Product ($ million) • Data Table on Market opportunity by Product ($ million) 9 Market Segmentation by Route of Administration 9.1 Market segments • Chart on Route of Administration - Market share 2025-2030 (%) • Data Table on Route of Administration - Market share 2025-2030 (%) 9.2 Comparison by Route of Administration • Chart on Comparison by Route of Administration • Data Table on Comparison by Route of Administration 9.3 Injectable - Market size and forecast 2025-2030 • Chart on Injectable - Market size and forecast 2025-2030 ($ million) • Data Table on Injectable - Market size and forecast 2025-2030 ($ million) • Chart on Injectable - Year-over-year growth 2025-2030 (%) • Data Table on Injectable - Year-over-year growth 2025-2030 (%) 9.4 Oral - Market size and forecast 2025-2030 • Chart on Oral - Market size and forecast 2025-2030 ($ million) • Data Table on Oral - Market size and forecast 2025-2030 ($ million) • Chart on Oral - Year-over-year growth 2025-2030 (%) • Data Table on Oral - Year-over-year growth 2025-2030 (%) 9.5 Market opportunity by Route of Administration • Market opportunity by Route of Administration ($ million) • Data Table on Market opportunity by Route of Administration ($ million) 10 Market Segmentation by Type 10.1 Market segments • Chart on Type - Market share 2025-2030 (%) • Data Table on Type - Market share 2025-2030 (%) 10.2 Comparison by Type • Chart on Comparison by Type • Data Table on Comparison by Type 10.3 Breast cancer - Market size and forecast 2025-2030 • Chart on Breast cancer - Market size and forecast 2025-2030 ($ million) • Data Table on Breast cancer - Market size and forecast 2025-2030 ($ million) • Chart on Breast cancer - Year-over-year growth 2025-2030 (%) • Data Table on Breast cancer - Year-over-year growth 2025-2030 (%) 10.4 Lung cancer - Market size and forecast 2025-2030 • Chart on Lung cancer - Market size and forecast 2025-2030 ($ million) • Data Table on Lung cancer - Market size and forecast 2025-2030 ($ million) • Chart on Lung cancer - Year-over-year growth 2025-2030 (%) • Data Table on Lung cancer - Year-over-year growth 2025-2030 (%) 10.5 Prostate cancer - Market size and forecast 2025-2030 • Chart on Prostate cancer - Market size and forecast 2025-2030 ($ million) • Data Table on Prostate cancer - Market size and forecast 2025-2030 ($ million) • Chart on Prostate cancer - Year-over-year growth 2025-2030 (%) • Data Table on Prostate cancer - Year-over-year growth 2025-2030 (%) 10.6 Colorectal cancer - Market size and forecast 2025-2030 • Chart on Colorectal cancer - Market size and forecast 2025-2030 ($ million) • Data Table on Colorectal cancer - Market size and forecast 2025-2030 ($ million) • Chart on Colorectal cancer - Year-over-year growth 2025-2030 (%) • Data Table on Colorectal cancer - Year-over-year growth 2025-2030 (%) 10.7 Others - Market size and forecast 2025-2030 • Chart on Others - Market size and forecast 2025-2030 ($ million) • Data Table on Others - Market size and forecast 2025-2030 ($ million) • Chart on Others - Year-over-year growth 2025-2030 (%) • Data Table on Others - Year-over-year growth 2025-2030 (%) 10.8 Market opportunity by Type • Market opportunity by Type ($ million) • Data Table on Market opportunity by Type ($ million) 11 Market Segmentation by End-user 11.1 Market segments • Chart on End-user - Market share 2025-2030 (%) • Data Table on End-user - Market share 2025-2030 (%) 11.2 Comparison by End-user • Chart on Comparison by End-user • Data Table on Comparison by End-user 11.3 Hospitals - Market size and forecast 2025-2030 • Chart on Hospitals - Market size and forecast 2025-2030 ($ million) • Data Table on Hospitals - Market size and forecast 2025-2030 ($ million) • Chart on Hospitals - Year-over-year growth 2025-2030 (%) • Data Table on Hospitals - Year-over-year growth 2025-2030 (%) 11.4 Specialized cancer centers - Market size and forecast 2025-2030 • Chart on Specialized cancer centers - Market size and forecast 2025-2030 ($ million) • Data Table on Specialized cancer centers - Market size and forecast 2025-2030 ($ million) • Chart on Specialized cancer centers - Year-over-year growth 2025-2030 (%) • Data Table on Specialized cancer centers - Year-over-year growth 2025-2030 (%) 11.5 Academic and research institutes - Market size and forecast 2025-2030 • Chart on Academic and research institutes - Market size and forecast 2025-2030 ($ million) • Data Table on Academic and research institutes - Market size and forecast 2025-2030 ($ million) • Chart on Academic and research institutes - Year-over-year growth 2025-2030 (%) • Data Table on Academic and research institutes - Year-over-year growth 2025-2030 (%) 11.6 Market opportunity by End-user • Market opportunity by End-user ($ million) • Data Table on Market opportunity by End-user ($ million) 12 Customer Landscape 12.1 Customer landscape overview • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria 13 Geographic Landscape 13.1 Geographic segmentation • Chart on Market share by geography 2025-2030 (%) • Data Table on Market share by geography 2025-2030 (%) 13.2 Geographic comparison • Chart on Geographic comparison • Data Table on Geographic comparison 13.3 North America - Market size and forecast 2025-2030 • Chart on North America - Market size and forecast 2025-2030 ($ million) • Data Table on North America - Market size and forecast 2025-2030 ($ million) • Chart on North America - Year-over-year growth 2025-2030 (%) • Data Table on North America - Year-over-year growth 2025-2030 (%) • Chart on Regional Comparison - North America • Data Table on Regional Comparison - North America 13.3.1 US - Market size and forecast 2025-2030 • Chart on US - Market size and forecast 2025-2030 ($ million) • Data Table on US - Market size and forecast 2025-2030 ($ million) • Chart on US - Year-over-year growth 2025-2030 (%) • Data Table on US - Year-over-year growth 2025-2030 (%) 13.3.2 Canada - Market size and forecast 2025-2030 • Chart on Canada - Market size and forecast 2025-2030 ($ million) • Data Table on Canada - Market size and forecast 2025-2030 ($ million) • Chart on Canada - Year-over-year growth 2025-2030 (%) • Data Table on Canada - Year-over-year growth 2025-2030 (%) 13.3.3 Mexico - Market size and forecast 2025-2030 • Chart on Mexico - Market size and forecast 2025-2030 ($ million) • Data Table on Mexico - Market size and forecast 2025-2030 ($ million) • Chart on Mexico - Year-over-year growth 2025-2030 (%) • Data Table on Mexico - Year-over-year growth 2025-2030 (%) 13.4 Europe - Market size and forecast 2025-2030 • Chart on Europe - Market size and forecast 2025-2030 ($ million) • Data Table on Europe - Market size and forecast 2025-2030 ($ million) • Chart on Europe - Year-over-year growth 2025-2030 (%) • Data Table on Europe - Year-over-year growth 2025-2030 (%) • Chart on Regional Comparison - Europe • Data Table on Regional Comparison - Europe 13.4.1 Germany - Market size and forecast 2025-2030 • Chart on Germany - Market size and forecast 2025-2030 ($ million) • Data Table on Germany - Market size and forecast 2025-2030 ($ million) • Chart on Germany - Year-over-year growth 2025-2030 (%) • Data Table on Germany - Year-over-year growth 2025-2030 (%) 13.4.2 UK - Market size and forecast 2025-2030 • Chart on UK - Market size and forecast 2025-2030 ($ million) • Data Table on UK - Market size and forecast 2025-2030 ($ million) • Chart on UK - Year-over-year growth 2025-2030 (%) • Data Table on UK - Year-over-year growth 2025-2030 (%) 13.4.3 France - Market size and forecast 2025-2030 • Chart on France - Market size and forecast 2025-2030 ($ million) • Data Table on France - Market size and forecast 2025-2030 ($ million) • Chart on France - Year-over-year growth 2025-2030 (%) • Data Table on France - Year-over-year growth 2025-2030 (%) 13.4.4 Italy - Market size and forecast 2025-2030 • Chart on Italy - Market size and forecast 2025-2030 ($ million) • Data Table on Italy - Market size and forecast 2025-2030 ($ million) • Chart on Italy - Year-over-year growth 2025-2030 (%) • Data Table on Italy - Year-over-year growth 2025-2030 (%) 13.4.5 Spain - Market size and forecast 2025-2030 • Chart on Spain - Market size and forecast 2025-2030 ($ million) • Data Table on Spain - Market size and forecast 2025-2030 ($ million) • Chart on Spain - Year-over-year growth 2025-2030 (%) • Data Table on Spain - Year-over-year growth 2025-2030 (%) 13.4.6 The Netherlands - Market size and forecast 2025-2030 • Chart on The Netherlands - Market size and forecast 2025-2030 ($ million) • Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million) • Chart on The Netherlands - Year-over-year growth 2025-2030 (%) • Data Table on The Netherlands - Year-over-year growth 2025-2030 (%) 13.5 Asia - Market size and forecast 2025-2030 • Chart on Asia - Market size and forecast 2025-2030 ($ million) • Data Table on Asia - Market size and forecast 2025-2030 ($ million) • Chart on Asia - Year-over-year growth 2025-2030 (%) • Data Table on Asia - Year-over-year growth 2025-2030 (%) • Chart on Regional Comparison - Asia • Data Table on Regional Comparison - Asia 13.5.1 China - Market size and forecast 2025-2030 • Chart on China - Market size and forecast 2025-2030 ($ million) • Data Table on China - Market size and forecast 2025-2030 ($ million) • Chart on China - Year-over-year growth 2025-2030 (%) • Data Table on China - Year-over-year growth 2025-2030 (%) 13.5.2 Japan - Market size and forecast 2025-2030 • Chart on Japan - Market size and forecast 2025-2030 ($ million) • Data Table on Japan - Market size and forecast 2025-2030 ($ million) • Chart on Japan - Year-over-year growth 2025-2030 (%) • Data Table on Japan - Year-over-year growth 2025-2030 (%) 13.5.3 India - Market size and forecast 2025-2030 • Chart on India - Market size and forecast 2025-2030 ($ million) • Data Table on India - Market size and forecast 2025-2030 ($ million) • Chart on India - Year-over-year growth 2025-2030 (%) • Data Table on India - Year-over-year growth 2025-2030 (%) 13.5.4 South Korea - Market size and forecast 2025-2030 • Chart on South Korea - Market size and forecast 2025-2030 ($ million) • Data Table on South Korea - Market size and forecast 2025-2030 ($ million) • Chart on South Korea - Year-over-year growth 2025-2030 (%) • Data Table on South Korea - Year-over-year growth 2025-2030 (%) 13.5.5 Taiwan - Market size and forecast 2025-2030 • Chart on Taiwan - Market size and forecast 2025-2030 ($ million) • Data Table on Taiwan - Market size and forecast 2025-2030 ($ million) • Chart on Taiwan - Year-over-year growth 2025-2030 (%) • Data Table on Taiwan - Year-over-year growth 2025-2030 (%) 13.5.6 Thailand - Market size and forecast 2025-2030 • Chart on Thailand - Market size and forecast 2025-2030 ($ million) • Data Table on Thailand - Market size and forecast 2025-2030 ($ million) • Chart on Thailand - Year-over-year growth 2025-2030 (%) • Data Table on Thailand - Year-over-year growth 2025-2030 (%) 13.6 Rest of World (ROW) - Market size and forecast 2025-2030 • Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million) • Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million) • Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%) • Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%) • Chart on Regional Comparison - Rest of World (ROW) • Data Table on Regional Comparison - Rest of World (ROW) 13.6.1 Brazil - Market size and forecast 2025-2030 • Chart on Brazil - Market size and forecast 2025-2030 ($ million) • Data Table on Brazil - Market size and forecast 2025-2030 ($ million) • Chart on Brazil - Year-over-year growth 2025-2030 (%) • Data Table on Brazil - Year-over-year growth 2025-2030 (%) 13.6.2 Saudi Arabia - Market size and forecast 2025-2030 • Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million) • Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million) • Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%) • Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%) 13.6.3 UAE - Market size and forecast 2025-2030 • Chart on UAE - Market size and forecast 2025-2030 ($ million) • Data Table on UAE - Market size and forecast 2025-2030 ($ million) • Chart on UAE - Year-over-year growth 2025-2030 (%) • Data Table on UAE - Year-over-year growth 2025-2030 (%) 13.6.4 South Africa - Market size and forecast 2025-2030 • Chart on South Africa - Market size and forecast 2025-2030 ($ million) • Data Table on South Africa - Market size and forecast 2025-2030 ($ million) • Chart on South Africa - Year-over-year growth 2025-2030 (%) • Data Table on South Africa - Year-over-year growth 2025-2030 (%) 13.6.5 Argentina - Market size and forecast 2025-2030 • Chart on Argentina - Market size and forecast 2025-2030 ($ million) • Data Table on Argentina - Market size and forecast 2025-2030 ($ million) • Chart on Argentina - Year-over-year growth 2025-2030 (%) • Data Table on Argentina - Year-over-year growth 2025-2030 (%) 13.6.6 Turkey - Market size and forecast 2025-2030 • Chart on Turkey - Market size and forecast 2025-2030 ($ million) • Data Table on Turkey - Market size and forecast 2025-2030 ($ million) • Chart on Turkey - Year-over-year growth 2025-2030 (%) • Data Table on Turkey - Year-over-year growth 2025-2030 (%) 13.6.7 Israel - Market size and forecast 2025-2030 • Chart on Israel - Market size and forecast 2025-2030 ($ million) • Data Table on Israel - Market size and forecast 2025-2030 ($ million) • Chart on Israel - Year-over-year growth 2025-2030 (%) • Data Table on Israel - Year-over-year growth 2025-2030 (%) 13.6.8 Chile - Market size and forecast 2025-2030 • Chart on Chile - Market size and forecast 2025-2030 ($ million) • Data Table on Chile - Market size and forecast 2025-2030 ($ million) • Chart on Chile - Year-over-year growth 2025-2030 (%) • Data Table on Chile - Year-over-year growth 2025-2030 (%) 13.7 Market opportunity by geography • Market opportunity by geography ($ million) • Data Tables on Market opportunity by geography ($ million) 14 Drivers, Challenges, and Opportunity 14.1 Market drivers • Escalating prevalence of oncology indications and aging demographics • Technological advancements in recombinant DNA and antibody engineering • Favorable regulatory frameworks and expedited approval pathways 14.2 Market challenges • High manufacturing costs and complex production processes • Stringent regulatory hurdles and extended approval timelines • Reimbursement complexities and substantial treatment costs 14.3 Impact of drivers and challenges • Impact of drivers and challenges in 2025 and 2030 14.4 Market opportunities • Proliferation of personalized medicine and precision oncology • Expansion of biosimilar adoption and market penetration • Integration of AI and ML in drug discovery 15 Competitive Landscape 15.1 Overview 15.2 Competitive Landscape • Overview on criticality of inputs and factors of differentiation 15.3 Landscape disruption • Overview on factors of disruption 15.4 Industry risks • Impact of key risks on business 16 Competitive Analysis 16.1 Companies profiled • Companies covered 16.2 Company ranking index • Company ranking index 16.3 Market positioning of companies • Matrix on companies position and classification 16.4 AbbVie Inc. • AbbVie Inc. - Overview • AbbVie Inc. - Business segments • AbbVie Inc. - Key news • AbbVie Inc. - Key offerings • AbbVie Inc. - Segment focus • SWOT 16.5 Amgen Inc. • Amgen Inc. - Overview • Amgen Inc. - Product / Service • Amgen Inc. - Key news • Amgen Inc. - Key offerings • SWOT 16.6 AstraZeneca Plc • AstraZeneca Plc - Overview • AstraZeneca Plc - Business segments • AstraZeneca Plc - Key news • AstraZeneca Plc - Key offerings • AstraZeneca Plc - Segment focus • SWOT 16.7 Bayer AG • Bayer AG - Overview • Bayer AG - Business segments • Bayer AG - Key news • Bayer AG - Key offerings • Bayer AG - Segment focus • SWOT 16.8 Bristol Myers Squibb Co. • Bristol Myers Squibb Co. - Overview • Bristol Myers Squibb Co. - Product / Service • Bristol Myers Squibb Co. - Key news • Bristol Myers Squibb Co. - Key offerings • SWOT 16.9 Cipla Inc. • Cipla Inc. - Overview • Cipla Inc. - Business segments • Cipla Inc. - Key news • Cipla Inc. - Key offerings • Cipla Inc. - Segment focus • SWOT 16.10 CSL Ltd. • CSL Ltd. - Overview • CSL Ltd. - Business segments • CSL Ltd. - Key offerings • CSL Ltd. - Segment focus • SWOT 16.11 Dr. Reddys Laboratories Ltd. • Dr. Reddys Laboratories Ltd. - Overview • Dr. Reddys Laboratories Ltd. - Business segments • Dr. Reddys Laboratories Ltd. - Key news • Dr. Reddys Laboratories Ltd. - Key offerings • Dr. Reddys Laboratories Ltd. - Segment focus • SWOT 16.12 Eli Lilly and Co. • Eli Lilly and Co. - Overview • Eli Lilly and Co. - Product / Service • Eli Lilly and Co. - Key news • Eli Lilly and Co. - Key offerings • SWOT 16.13 Johnson and Johnson • Johnson and Johnson - Overview • Johnson and Johnson - Business segments • Johnson and Johnson - Key news • Johnson and Johnson - Key offerings • Johnson and Johnson - Segment focus • SWOT 16.14 Lupin Ltd. • Lupin Ltd. - Overview • Lupin Ltd. - Business segments • Lupin Ltd. - Key news • Lupin Ltd. - Key offerings • Lupin Ltd. - Segment focus • SWOT 16.15 Merck and Co. Inc. • Merck and Co. Inc. - Overview • Merck and Co. Inc. - Business segments • Merck and Co. Inc. - Key news • Merck and Co. Inc. - Key offerings • Merck and Co. Inc. - Segment focus • SWOT 16.16 Novartis AG • Novartis AG - Overview • Novartis AG - Business segments • Novartis AG - Key news • Novartis AG - Key offerings • Novartis AG - Segment focus • SWOT 16.17 Pfizer Inc. • Pfizer Inc. - Overview • Pfizer Inc. - Business segments • Pfizer Inc. - Key news • Pfizer Inc. - Key offerings • Pfizer Inc. - Segment focus • SWOT 16.18 Sanofi SA • Sanofi SA - Overview • Sanofi SA - Business segments • Sanofi SA - Key news • Sanofi SA - Key offerings • Sanofi SA - Segment focus • SWOT 17 Appendix 17.1 Scope of the report • Market definition • Objectives • Notes and caveats 17.2 Inclusions and exclusions checklist • Inclusions checklist • Exclusions checklist 17.3 Currency conversion rates for US$ • Currency conversion rates for US$ 17.4 Research methodology • Research methodology 17.5 Data procurement • Information sources 17.6 Data validation • Data validation 17.7 Validation techniques employed for market sizing • Validation techniques employed for market sizing 17.8 Data synthesis • Data synthesis 17.9 360 degree market analysis • 360 degree market analysis 17.10 List of abbreviations • List of abbreviations List of Tables/GraphsExhibits1: Executive Summary - Chart on Market OverviewExhibits2: Executive Summary - Data Table on Market Overview Exhibits3: Executive Summary - Chart on Global Market Characteristics Exhibits4: Executive Summary - Chart on Market by Geography Exhibits5: Executive Summary - Chart on Market Segmentation by Product Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration Exhibits7: Executive Summary - Chart on Market Segmentation by Type Exhibits8: Executive Summary - Chart on Market Segmentation by End-user Exhibits9: Executive Summary - Chart on Incremental Growth Exhibits10: Executive Summary - Data Table on Incremental Growth Exhibits11: Executive Summary - Chart on Company Market Positioning Exhibits12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Exhibits13: Chart on Overview on criticality of inputs and factors of differentiation Exhibits14: Chart on Overview on factors of disruption Exhibits15: Chart on Impact of drivers and challenges in 2025 and 2030 Exhibits16: Chart on Parent Market Exhibits17: Data Table on - Parent Market Exhibits18: Chart on Market characteristics analysis Exhibits19: Chart on Value chain analysis Exhibits20: Data Table on Offerings of companies included in the market definition Exhibits21: Market segments Exhibits22: Chart on Global - Market size and forecast 2025-2030 ($ million) Exhibits23: Data Table on Global - Market size and forecast 2025-2030 ($ million) Exhibits24: Chart on Global Market: Year-over-year growth 2025-2030 (%) Exhibits25: Data Table on Global Market: Year-over-year growth 2025-2030 (%) Exhibits26: Historic Market Size - Data Table on Global Cancer Biologics Market 2020 - 2024 ($ million) Exhibits27: Historic Market Size - Product Segment 2020 - 2024 ($ million) Exhibits28: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million) Exhibits29: Historic Market Size - Type Segment 2020 - 2024 ($ million) Exhibits30: Historic Market Size - End-user Segment 2020 - 2024 ($ million) Exhibits31: Historic Market Size - Geography Segment 2020 - 2024 ($ million) Exhibits32: Historic Market Size - Country Segment 2020 - 2024 ($ million) Exhibits33: Five forces analysis - Comparison between 2025 and 2030 Exhibits34: Bargaining power of buyers - Impact of key factors 2025 and 2030 Exhibits35: Bargaining power of suppliers - Impact of key factors in 2025 and 2030 Exhibits36: Threat of new entrants - Impact of key factors in 2025 and 2030 Exhibits37: Threat of substitutes - Impact of key factors in 2025 and 2030 Exhibits38: Threat of rivalry - Impact of key factors in 2025 and 2030 Exhibits39: Chart on Market condition - Five forces 2025 and 2030 Exhibits40: Chart on Product - Market share 2025-2030 (%) Exhibits41: Data Table on Product - Market share 2025-2030 (%) Exhibits42: Chart on Comparison by Product Exhibits43: Data Table on Comparison by Product Exhibits44: Chart on Monoclonal antibodies - Market size and forecast 2025-2030 ($ million) Exhibits45: Data Table on Monoclonal antibodies - Market size and forecast 2025-2030 ($ million) Exhibits46: Chart on Monoclonal antibodies - Year-over-year growth 2025-2030 (%) Exhibits47: Data Table on Monoclonal antibodies - Year-over-year growth 2025-2030 (%) Exhibits48: Chart on Cell and gene therapy - Market size and forecast 2025-2030 ($ million) Exhibits49: Data Table on Cell and gene therapy - Market size and forecast 2025-2030 ($ million) Exhibits50: Chart on Cell and gene therapy - Year-over-year growth 2025-2030 (%) Exhibits51: Data Table on Cell and gene therapy - Year-over-year growth 2025-2030 (%) Exhibits52: Chart on Vaccines - Market size and forecast 2025-2030 ($ million) Exhibits53: Data Table on Vaccines - Market size and forecast 2025-2030 ($ million) Exhibits54: Chart on Vaccines - Year-over-year growth 2025-2030 (%) Exhibits55: Data Table on Vaccines - Year-over-year growth 2025-2030 (%) Exhibits56: Chart on Others - Market size and forecast 2025-2030 ($ million) Exhibits57: Data Table on Others - Market size and forecast 2025-2030 ($ million) Exhibits58: Chart on Others - Year-over-year growth 2025-2030 (%) Exhibits59: Data Table on Others - Year-over-year growth 2025-2030 (%) Exhibits60: Market opportunity by Product ($ million) Exhibits61: Data Table on Market opportunity by Product ($ million) Exhibits62: Chart on Route of Administration - Market share 2025-2030 (%) Exhibits63: Data Table on Route of Administration - Market share 2025-2030 (%) Exhibits64: Chart on Comparison by Route of Administration Exhibits65: Data Table on Comparison by Route of Administration Exhibits66: Chart on Injectable - Market size and forecast 2025-2030 ($ million) Exhibits67: Data Table on Injectable - Market size and forecast 2025-2030 ($ million) Exhibits68: Chart on Injectable - Year-over-year growth 2025-2030 (%) Exhibits69: Data Table on Injectable - Year-over-year growth 2025-2030 (%) Exhibits70: Chart on Oral - Market size and forecast 2025-2030 ($ million) Exhibits71: Data Table on Oral - Market size and forecast 2025-2030 ($ million) Exhibits72: Chart on Oral - Year-over-year growth 2025-2030 (%) Exhibits73: Data Table on Oral - Year-over-year growth 2025-2030 (%) Exhibits74: Market opportunity by Route of Administration ($ million) Exhibits75: Data Table on Market opportunity by Route of Administration ($ million) Exhibits76: Chart on Type - Market share 2025-2030 (%) Exhibits77: Data Table on Type - Market share 2025-2030 (%) Exhibits78: Chart on Comparison by Type Exhibits79: Data Table on Comparison by Type Exhibits80: Chart on Breast cancer - Market size and forecast 2025-2030 ($ million) Exhibits81: Data Table on Breast cancer - Market size and forecast 2025-2030 ($ million) Exhibits82: Chart on Breast cancer - Year-over-year growth 2025-2030 (%) Exhibits83: Data Table on Breast cancer - Year-over-year growth 2025-2030 (%) Exhibits84: Chart on Lung cancer - Market size and forecast 2025-2030 ($ million) Exhibits85: Data Table on Lung cancer - Market size and forecast 2025-2030 ($ million) Exhibits86: Chart on Lung cancer - Year-over-year growth 2025-2030 (%) Exhibits87: Data Table on Lung cancer - Year-over-year growth 2025-2030 (%) Exhibits88: Chart on Prostate cancer - Market size and forecast 2025-2030 ($ million) Exhibits89: Data Table on Prostate cancer - Market size and forecast 2025-2030 ($ million) Exhibits90: Chart on Prostate cancer - Year-over-year growth 2025-2030 (%) Exhibits91: Data Table on Prostate cancer - Year-over-year growth 2025-2030 (%) Exhibits92: Chart on Colorectal cancer - Market size and forecast 2025-2030 ($ million) Exhibits93: Data Table on Colorectal cancer - Market size and forecast 2025-2030 ($ million) Exhibits94: Chart on Colorectal cancer - Year-over-year growth 2025-2030 (%) Exhibits95: Data Table on Colorectal cancer - Year-over-year growth 2025-2030 (%) Exhibits96: Chart on Others - Market size and forecast 2025-2030 ($ million) Exhibits97: Data Table on Others - Market size and forecast 2025-2030 ($ million) Exhibits98: Chart on Others - Year-over-year growth 2025-2030 (%) Exhibits99: Data Table on Others - Year-over-year growth 2025-2030 (%) Exhibits100: Market opportunity by Type ($ million) Exhibits101: Data Table on Market opportunity by Type ($ million) Exhibits102: Chart on End-user - Market share 2025-2030 (%) Exhibits103: Data Table on End-user - Market share 2025-2030 (%) Exhibits104: Chart on Comparison by End-user Exhibits105: Data Table on Comparison by End-user Exhibits106: Chart on Hospitals - Market size and forecast 2025-2030 ($ million) Exhibits107: Data Table on Hospitals - Market size and forecast 2025-2030 ($ million) Exhibits108: Chart on Hospitals - Year-over-year growth 2025-2030 (%) Exhibits109: Data Table on Hospitals - Year-over-year growth 2025-2030 (%) Exhibits110: Chart on Specialized cancer centers - Market size and forecast 2025-2030 ($ million) Exhibits111: Data Table on Specialized cancer centers - Market size and forecast 2025-2030 ($ million) Exhibits112: Chart on Specialized cancer centers - Year-over-year growth 2025-2030 (%) Exhibits113: Data Table on Specialized cancer centers - Year-over-year growth 2025-2030 (%) Exhibits114: Chart on Academic and research institutes - Market size and forecast 2025-2030 ($ million) Exhibits115: Data Table on Academic and research institutes - Market size and forecast 2025-2030 ($ million) Exhibits116: Chart on Academic and research institutes - Year-over-year growth 2025-2030 (%) Exhibits117: Data Table on Academic and research institutes - Year-over-year growth 2025-2030 (%) Exhibits118: Market opportunity by End-user ($ million) Exhibits119: Data Table on Market opportunity by End-user ($ million) Exhibits120: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Exhibits121: Chart on Market share by geography 2025-2030 (%) Exhibits122: Data Table on Market share by geography 2025-2030 (%) Exhibits123: Chart on Geographic comparison Exhibits124: Data Table on Geographic comparison Exhibits125: Chart on North America - Market size and forecast 2025-2030 ($ million) Exhibits126: Data Table on North America - Market size and forecast 2025-2030 ($ million) Exhibits127: Chart on North America - Year-over-year growth 2025-2030 (%) Exhibits128: Data Table on North America - Year-over-year growth 2025-2030 (%) Exhibits129: Chart on Regional Comparison - North America Exhibits130: Data Table on Regional Comparison - North America Exhibits131: Chart on US - Market size and forecast 2025-2030 ($ million) Exhibits132: Data Table on US - Market size and forecast 2025-2030 ($ million) Exhibits133: Chart on US - Year-over-year growth 2025-2030 (%) Exhibits134: Data Table on US - Year-over-year growth 2025-2030 (%) Exhibits135: Chart on Canada - Market size and forecast 2025-2030 ($ million) Exhibits136: Data Table on Canada - Market size and forecast 2025-2030 ($ million) Exhibits137: Chart on Canada - Year-over-year growth 2025-2030 (%) Exhibits138: Data Table on Canada - Year-over-year growth 2025-2030 (%) Exhibits139: Chart on Mexico - Market size and forecast 2025-2030 ($ million) Exhibits140: Data Table on Mexico - Market size and forecast 2025-2030 ($ million) Exhibits141: Chart on Mexico - Year-over-year growth 2025-2030 (%) Exhibits142: Data Table on Mexico - Year-over-year growth 2025-2030 (%) Exhibits143: Chart on Europe - Market size and forecast 2025-2030 ($ million) Exhibits144: Data Table on Europe - Market size and forecast 2025-2030 ($ million) Exhibits145: Chart on Europe - Year-over-year growth 2025-2030 (%) Exhibits146: Data Table on Europe - Year-over-year growth 2025-2030 (%) Exhibits147: Chart on Regional Comparison - Europe Exhibits148: Data Table on Regional Comparison - Europe Exhibits149: Chart on Germany - Market size and forecast 2025-2030 ($ million) Exhibits150: Data Table on Germany - Market size and forecast 2025-2030 ($ million) Exhibits151: Chart on Germany - Year-over-year growth 2025-2030 (%) Exhibits152: Data Table on Germany - Year-over-year growth 2025-2030 (%) Exhibits153: Chart on UK - Market size and forecast 2025-2030 ($ million) Exhibits154: Data Table on UK - Market size and forecast 2025-2030 ($ million) Exhibits155: Chart on UK - Year-over-year growth 2025-2030 (%) Exhibits156: Data Table on UK - Year-over-year growth 2025-2030 (%) Exhibits157: Chart on France - Market size and forecast 2025-2030 ($ million) Exhibits158: Data Table on France - Market size and forecast 2025-2030 ($ million) Exhibits159: Chart on France - Year-over-year growth 2025-2030 (%) Exhibits160: Data Table on France - Year-over-year growth 2025-2030 (%) Exhibits161: Chart on Italy - Market size and forecast 2025-2030 ($ million) Exhibits162: Data Table on Italy - Market size and forecast 2025-2030 ($ million) Exhibits163: Chart on Italy - Year-over-year growth 2025-2030 (%) Exhibits164: Data Table on Italy - Year-over-year growth 2025-2030 (%) Exhibits165: Chart on Spain - Market size and forecast 2025-2030 ($ million) Exhibits166: Data Table on Spain - Market size and forecast 2025-2030 ($ million) Exhibits167: Chart on Spain - Year-over-year growth 2025-2030 (%) Exhibits168: Data Table on Spain - Year-over-year growth 2025-2030 (%) Exhibits169: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million) Exhibits170: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million) Exhibits171: Chart on The Netherlands - Year-over-year growth 2025-2030 (%) Exhibits172: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%) Exhibits173: Chart on Asia - Market size and forecast 2025-2030 ($ million) Exhibits174: Data Table on Asia - Market size and forecast 2025-2030 ($ million) Exhibits175: Chart on Asia - Year-over-year growth 2025-2030 (%) Exhibits176: Data Table on Asia - Year-over-year growth 2025-2030 (%) Exhibits177: Chart on Regional Comparison - Asia Exhibits178: Data Table on Regional Comparison - Asia Exhibits179: Chart on China - Market size and forecast 2025-2030 ($ million) Exhibits180: Data Table on China - Market size and forecast 2025-2030 ($ million) Exhibits181: Chart on China - Year-over-year growth 2025-2030 (%) Exhibits182: Data Table on China - Year-over-year growth 2025-2030 (%) Exhibits183: Chart on Japan - Market size and forecast 2025-2030 ($ million) Exhibits184: Data Table on Japan - Market size and forecast 2025-2030 ($ million) Exhibits185: Chart on Japan - Year-over-year growth 2025-2030 (%) Exhibits186: Data Table on Japan - Year-over-year growth 2025-2030 (%) Exhibits187: Chart on India - Market size and forecast 2025-2030 ($ million) Exhibits188: Data Table on India - Market size and forecast 2025-2030 ($ million) Exhibits189: Chart on India - Year-over-year growth 2025-2030 (%) Exhibits190: Data Table on India - Year-over-year growth 2025-2030 (%) Exhibits191: Chart on South Korea - Market size and forecast 2025-2030 ($ million) Exhibits192: Data Table on South Korea - Market size and forecast 2025-2030 ($ million) Exhibits193: Chart on South Korea - Year-over-year growth 2025-2030 (%) Exhibits194: Data Table on South Korea - Year-over-year growth 2025-2030 (%) Exhibits195: Chart on Taiwan - Market size and forecast 2025-2030 ($ million) Exhibits196: Data Table on Taiwan - Market size and forecast 2025-2030 ($ million) Exhibits197: Chart on Taiwan - Year-over-year growth 2025-2030 (%) Exhibits198: Data Table on Taiwan - Year-over-year growth 2025-2030 (%) Exhibits199: Chart on Thailand - Market size and forecast 2025-2030 ($ million) Exhibits200: Data Table on Thailand - Market size and forecast 2025-2030 ($ million) Exhibits201: Chart on Thailand - Year-over-year growth 2025-2030 (%) Exhibits202: Data Table on Thailand - Year-over-year growth 2025-2030 (%) Exhibits203: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million) Exhibits204: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million) Exhibits205: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%) Exhibits206: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%) Exhibits207: Chart on Regional Comparison - Rest of World (ROW) Exhibits208: Data Table on Regional Comparison - Rest of World (ROW) Exhibits209: Chart on Brazil - Market size and forecast 2025-2030 ($ million) Exhibits210: Data Table on Brazil - Market size and forecast 2025-2030 ($ million) Exhibits211: Chart on Brazil - Year-over-year growth 2025-2030 (%) Exhibits212: Data Table on Brazil - Year-over-year growth 2025-2030 (%) Exhibits213: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million) Exhibits214: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million) Exhibits215: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%) Exhibits216: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%) Exhibits217: Chart on UAE - Market size and forecast 2025-2030 ($ million) Exhibits218: Data Table on UAE - Market size and forecast 2025-2030 ($ million) Exhibits219: Chart on UAE - Year-over-year growth 2025-2030 (%) Exhibits220: Data Table on UAE - Year-over-year growth 2025-2030 (%) Exhibits221: Chart on South Africa - Market size and forecast 2025-2030 ($ million) Exhibits222: Data Table on South Africa - Market size and forecast 2025-2030 ($ million) Exhibits223: Chart on South Africa - Year-over-year growth 2025-2030 (%) Exhibits224: Data Table on South Africa - Year-over-year growth 2025-2030 (%) Exhibits225: Chart on Argentina - Market size and forecast 2025-2030 ($ million) Exhibits226: Data Table on Argentina - Market size and forecast 2025-2030 ($ million) Exhibits227: Chart on Argentina - Year-over-year growth 2025-2030 (%) Exhibits228: Data Table on Argentina - Year-over-year growth 2025-2030 (%) Exhibits229: Chart on Turkey - Market size and forecast 2025-2030 ($ million) Exhibits230: Data Table on Turkey - Market size and forecast 2025-2030 ($ million) Exhibits231: Chart on Turkey - Year-over-year growth 2025-2030 (%) Exhibits232: Data Table on Turkey - Year-over-year growth 2025-2030 (%) Exhibits233: Chart on Israel - Market size and forecast 2025-2030 ($ million) Exhibits234: Data Table on Israel - Market size and forecast 2025-2030 ($ million) Exhibits235: Chart on Israel - Year-over-year growth 2025-2030 (%) Exhibits236: Data Table on Israel - Year-over-year growth 2025-2030 (%) Exhibits237: Chart on Chile - Market size and forecast 2025-2030 ($ million) Exhibits238: Data Table on Chile - Market size and forecast 2025-2030 ($ million) Exhibits239: Chart on Chile - Year-over-year growth 2025-2030 (%) Exhibits240: Data Table on Chile - Year-over-year growth 2025-2030 (%) Exhibits241: Market opportunity by geography ($ million) Exhibits242: Data Tables on Market opportunity by geography ($ million) Exhibits243: Impact of drivers and challenges in 2025 and 2030 Exhibits244: Overview on criticality of inputs and factors of differentiation Exhibits245: Overview on factors of disruption Exhibits246: Impact of key risks on business Exhibits247: Companies covered Exhibits248: Company ranking index Exhibits249: Matrix on companies position and classification Exhibits250: AbbVie Inc. - Overview Exhibits251: AbbVie Inc. - Business segments Exhibits252: AbbVie Inc. - Key news Exhibits253: AbbVie Inc. - Key offerings Exhibits254: AbbVie Inc. - Segment focus Exhibits255: SWOT Exhibits256: Amgen Inc. - Overview Exhibits257: Amgen Inc. - Product / Service Exhibits258: Amgen Inc. - Key news Exhibits259: Amgen Inc. - Key offerings Exhibits260: SWOT Exhibits261: AstraZeneca Plc - Overview Exhibits262: AstraZeneca Plc - Business segments Exhibits263: AstraZeneca Plc - Key news Exhibits264: AstraZeneca Plc - Key offerings Exhibits265: AstraZeneca Plc - Segment focus Exhibits266: SWOT Exhibits267: Bayer AG - Overview Exhibits268: Bayer AG - Business segments Exhibits269: Bayer AG - Key news Exhibits270: Bayer AG - Key offerings Exhibits271: Bayer AG - Segment focus Exhibits272: SWOT Exhibits273: Bristol Myers Squibb Co. - Overview Exhibits274: Bristol Myers Squibb Co. - Product / Service Exhibits275: Bristol Myers Squibb Co. - Key news Exhibits276: Bristol Myers Squibb Co. - Key offerings Exhibits277: SWOT Exhibits278: Cipla Inc. - Overview Exhibits279: Cipla Inc. - Business segments Exhibits280: Cipla Inc. - Key news Exhibits281: Cipla Inc. - Key offerings Exhibits282: Cipla Inc. - Segment focus Exhibits283: SWOT Exhibits284: CSL Ltd. - Overview Exhibits285: CSL Ltd. - Business segments Exhibits286: CSL Ltd. - Key offerings Exhibits287: CSL Ltd. - Segment focus Exhibits288: SWOT Exhibits289: Dr. Reddys Laboratories Ltd. - Overview Exhibits290: Dr. Reddys Laboratories Ltd. - Business segments Exhibits291: Dr. Reddys Laboratories Ltd. - Key news Exhibits292: Dr. Reddys Laboratories Ltd. - Key offerings Exhibits293: Dr. Reddys Laboratories Ltd. - Segment focus Exhibits294: SWOT Exhibits295: Eli Lilly and Co. - Overview Exhibits296: Eli Lilly and Co. - Product / Service Exhibits297: Eli Lilly and Co. - Key news Exhibits298: Eli Lilly and Co. - Key offerings Exhibits299: SWOT Exhibits300: Johnson and Johnson - Overview Exhibits301: Johnson and Johnson - Business segments Exhibits302: Johnson and Johnson - Key news Exhibits303: Johnson and Johnson - Key offerings Exhibits304: Johnson and Johnson - Segment focus Exhibits305: SWOT Exhibits306: Lupin Ltd. - Overview Exhibits307: Lupin Ltd. - Business segments Exhibits308: Lupin Ltd. - Key news Exhibits309: Lupin Ltd. - Key offerings Exhibits310: Lupin Ltd. - Segment focus Exhibits311: SWOT Exhibits312: Merck and Co. Inc. - Overview Exhibits313: Merck and Co. Inc. - Business segments Exhibits314: Merck and Co. Inc. - Key news Exhibits315: Merck and Co. Inc. - Key offerings Exhibits316: Merck and Co. Inc. - Segment focus Exhibits317: SWOT Exhibits318: Novartis AG - Overview Exhibits319: Novartis AG - Business segments Exhibits320: Novartis AG - Key news Exhibits321: Novartis AG - Key offerings Exhibits322: Novartis AG - Segment focus Exhibits323: SWOT Exhibits324: Pfizer Inc. - Overview Exhibits325: Pfizer Inc. - Business segments Exhibits326: Pfizer Inc. - Key news Exhibits327: Pfizer Inc. - Key offerings Exhibits328: Pfizer Inc. - Segment focus Exhibits329: SWOT Exhibits330: Sanofi SA - Overview Exhibits331: Sanofi SA - Business segments Exhibits332: Sanofi SA - Key news Exhibits333: Sanofi SA - Key offerings Exhibits334: Sanofi SA - Segment focus Exhibits335: SWOT Exhibits336: Inclusions checklist Exhibits337: Exclusions checklist Exhibits338: Currency conversion rates for US$ Exhibits339: Research methodology Exhibits340: Information sources Exhibits341: Data validation Exhibits342: Validation techniques employed for market sizing Exhibits343: Data synthesis Exhibits344: 360 degree market analysis Exhibits345: List of abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポート
TechNavio社の Health Care分野 での最新刊レポート
本レポートと同じKEY WORD（cancer）の最新刊レポートよくあるご質問TechNavio社はどのような調査会社ですか?テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
